Product Type Fc Silent Antibody
Description Anti-Human DR5-Fc silent antibody is derived from clone PRO95780, which is a Human monoclonal antibody targeting the DR5. And it is intended for the research of Chondrosarcoma, colorectal cancer, non-Hodgkin lymphoma, and non-small cell lung cancer..
Research Area Cell Biology, Immunology
Antigen Distribution DR5 is widely expressed in adult and fetal tissues, with notably high expression on tumor cells.
Disease Chondrosarcoma, colorectal cancer, non-Hodgkin lymphoma, and non-small cell lung cancer.
Size 100 ug
Immunogen Recombinant Human DR5 protein
Species Human
Clonality Monoclonal
Clone Number PRO95780
Conjugation Unconjugated
Source Recombinant
Buffer PBS, pH 7.4
Application Agonist, ELISA, FuncS, FC, IF, IP, WB
Application Notes The use of diluent depends on the detection system used. It is recommended that users test reagents and determine their own optimal dilution.
Handling Advice This product is for research use only. It is not intended for use in therapeutic or diagnostic procedures for humans or animals.
Storage Instructions Product should be stored at -80°C. Repeated freeze and thaw cycles will cause loss of activity. Use product within 24 hours after thawing and keep on ice. Remainder amounts should be aliquoted and immediately re-freezed for future use. Aliquots should never be thawed more than once. Under recommended storage conditions, product is stable for at least one year.
Official Name Tumor necrosis factor receptor superfamily member 10B
Full Name Tumor necrosis factor receptor superfamily member 10B
Background DR5 is expressed in a variety of solid tumors and hematologic malignancies, which are characteristically resistant to apoptosis.
Alternative Names DR5; CD262; KILLER; TRICK2; TRICKB; ZTNFR9; TRAILR2; TRICK2A; TRICK2B; TRAIL-R2; KILLER/DR5
Gene ID 8795
Uniprot ID O14763
Related Products
All products and services are for Research Use Only. Do Not use in humans.
Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.